U.S. childhood vaccine availability: legal, regulatory, and economic complexities.
Despite the vital role they play in public health, childhood vaccines travel a complicated road from laboratory to provider and patient. From the fall of 2000 until well into 2002, a combination of factors, including market dynamics, legal challenges, and regulatory hurdles, led to a shortage of some childhood vaccines. This paper examines each of these factors, focusing on the important roles of both the public and the private sectors.
Strongin
Robin J
RJ
D002648:Child; D004345:Drug Industry; D006266:Health Education; D006291:Health Policy; D006301:Health Services Needs and Demand / Q000191:economics / Q000331:legislation & jurisprudence; D006801:Humans; D007114:Immunization / Q000191:economics / Q000331:legislation & jurisprudence; D017589:Immunization Programs / Q000191:economics / Q000331:legislation & jurisprudence / Q000600:supply & distribution; D017149:Private Sector; D011634:Public Health; D017150:Public Sector; D014481:United States; D014486:United States Food and Drug Administration; D014612:Vaccines / Q000191:economics / Q000600:supply & distribution
D014612:Vaccines